137 related articles for article (PubMed ID: 17766321)
1. Detection and reporting of drug-induced proarrhythmias: room for improvement.
Darpö B
Europace; 2007 Sep; 9 Suppl 4():iv23-36. PubMed ID: 17766321
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.
Layton D; Key C; Shakir SA
Pharmacoepidemiol Drug Saf; 2003; 12(1):31-40. PubMed ID: 12616845
[TBL] [Abstract][Full Text] [Related]
3. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
[TBL] [Abstract][Full Text] [Related]
4. [Cisapride and risk of cardiac complications].
Cataldo F
Minerva Pediatr; 1999; 51(9-10):309-11. PubMed ID: 10783591
[TBL] [Abstract][Full Text] [Related]
5. [The proarrhythmogenic activity of non-anti-arrhythmia drugs. Is treatment with antihistamines and cisapride safe?].
Pelov R; Tankova L; Krushkov I
Vutr Boles; 1999; 31(2-3):5-9. PubMed ID: 10847134
[TBL] [Abstract][Full Text] [Related]
6. [Risk of drug interactions. Combinations of drugs associated with ventricular arrhythmias].
Viramontes-Madrid JL; Jerjes-Sánchez C; Pelaez-Ballestas I; Aguilar-Chiu A; Hernández-Garduño AG
Rev Invest Clin; 2002; 54(3):192-7. PubMed ID: 12183887
[TBL] [Abstract][Full Text] [Related]
7. The impact of wording in "Dear doctor" letters and in black box labels.
Weatherby LB; Nordstrom BL; Fife D; Walker AM
Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
[TBL] [Abstract][Full Text] [Related]
8. [Long QT interval and malignant ventricular arrhythmia during treatment with cisapride. Report of a clinical case].
Massari FM; Trevano FQ; Diehl L; Romano S
Ital Heart J Suppl; 2000 Aug; 1(8):1055-8. PubMed ID: 10993015
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride.
Barbey JT; Lazzara R; Zipes DP
J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):65-76. PubMed ID: 12075394
[TBL] [Abstract][Full Text] [Related]
10. [Clinical proarrhythmias induced by anti-arrhythmic drugs, non-cardiovascular agents and implantable cardioverter-defibrillators].
Fazekas T; Liszkai G
Orv Hetil; 2002 Jan; 143(2):61-9. PubMed ID: 11868450
[TBL] [Abstract][Full Text] [Related]
11. Cisapride and patient information leaflets.
Sukkari SR; Sasich LD
CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
[No Abstract] [Full Text] [Related]
12. Lessons from cisapride.
CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
[No Abstract] [Full Text] [Related]
13. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
[TBL] [Abstract][Full Text] [Related]
14. New safety recommendations for use of cisapride (Propulsid).
Harv Heart Lett; 2000 Apr; 10(8):7. PubMed ID: 10712753
[No Abstract] [Full Text] [Related]
15. Quantitative signal detection using spontaneous ADR reporting.
Bate A; Evans SJ
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):427-36. PubMed ID: 19358225
[TBL] [Abstract][Full Text] [Related]
16. Prepulsid withdrawn from UK & US markets.
Griffin JP
Adverse Drug React Toxicol Rev; 2000 Aug; 19(3):177. PubMed ID: 11059358
[No Abstract] [Full Text] [Related]
17. Increase in mortality rate following coprescription of cisapride and contraindicated drugs.
Choi NK; Hahn S; Park BJ
Ann Pharmacother; 2007 Apr; 41(4):667-73. PubMed ID: 17374629
[TBL] [Abstract][Full Text] [Related]
18. Cisapride fallout? Canada to gain access to largest adverse-event database.
Sibbald B
CMAJ; 2002 Oct; 167(7):790. PubMed ID: 12389847
[No Abstract] [Full Text] [Related]
19. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada.
Walker AM; Szneke P; Weatherby LB; Dicker LW; Lanza LL; Loughlin JE; Yee CL; Dreyer NA
Am J Med; 1999 Oct; 107(4):356-62. PubMed ID: 10527038
[TBL] [Abstract][Full Text] [Related]
20. Cardiotoxic effects of antihistamines: from basics to clinics (...and back).
Soldovieri MV; Miceli F; Taglialatela M
Chem Res Toxicol; 2008 May; 21(5):997-1004. PubMed ID: 18442267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
